Trichomonas vaginalis P16 immunoreactivity in cervicovaginal Pap tests: A diagnostic pitfall.

Author Department

Pathology

Document Type

Article, Peer-reviewed

Publication Date

9-1-2005

Abstract

Detection of p16 is emerging as a useful biomarker for Human Papillomavirus (HPV)-related dysplastic and malignant lesions of the cervix, and as such has potential application to cervicovaginal Papanicolaou (Pap) specimens. While evaluating p16 immunocyto

Publication ISSN

0028-3878

Share

COinS